Evangelos J. Giamarellos-Bourboulis, Antigone Kotsaki, Ioanna Kotsamidi, Aikaterini Efthymiou, Vasiliki Koutsoukou, Johannes Ehler, Alexandra Paridou, Frantzeska Frantzeskaki, Marcella C. A. Müller, Peter Pickkers, Sylvain Meylan, Ioannis Nikolopoulos, Mihaela Lupse, Alexandra Gavala, Glykeria Vlachogianni, Nicky Solomonidi, Antonia Alevizou, Eumorfia Kondili, Eleni Antoniadou, Maria Nakou, Nikolaos Markou, Erifili Hatziagelaki, Athanassios Prekates, Apostolos Komnos, Lieke Bakkerus, Marleen A. Slim, George N. Dalekos, Areti Karapanagiotou, Sofia Ktena, Gennaro De Pascale, Vassileios Koulouras, Christos Psarrakis, Eleni Massa, Konstantina Dakou, Chrisoula Pazvanti, Aikaterini Ioakeimidou, Iraklis Tsangaris, Nikolaos Antonakos, Alexander P. J. Vlaar, Souzana Anisoglou, Thierry Calandra, Vasilios Papaioannou, Pavlos Myrianthefs, Maria Patrani, Ioannis Alamanos, Massimo Antonelli, Jos W. M. van der Meer, Tom van der Poll, W. Joost Wiersinga, Maria Ntaganou, Eleni Gkeka, Michael Bauer, Eleni Mouloudi, Mihai G. Netea, for the ImmunoSep Study Group
JAMA, December 08, 2025
DOI 10.1001/jama.2025.24175
Funding
The ImmunoSep trial has received funding from the European Union Horizon 2020 research and innovation programme under grant agreement 847422. Dr Netea was supported by grant OCENW.XL.23.055 from NWO-XL and by a Spinoza grant of the Netherlands Organization for Scientific Research.
Keywords: Sepsis; Critical care medicine; Infectious diseases; immunotherapy
Related Studies: ImmunoSep